APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atovaquone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atovaquone Market Analysis and Forecast 2026-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchAtovaquone Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Atovaquone Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Atovaquone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atovaquone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Atovaquone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Atovaquone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atovaquone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atovaquone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atovaquone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atovaquone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atovaquone include GSK, Amneal Pharmaceuticals, Lupin and Apotex, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atovaquone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atovaquone, also provides the sales of main regions and countries. Of the upcoming market potential for Atovaquone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atovaquone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atovaquone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atovaquone sales, projected growth trends, production technology, application and end-user industry.

Atovaquone Segment by Company

GSK

Amneal Pharmaceuticals

Lupin

Apotex

Atovaquone Segment by Type

250mg

500mg

Atovaquone Segment by Application

Hospital

Drug Store

Atovaquone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atovaquone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atovaquone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atovaquone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atovaquone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atovaquone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atovaquone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atovaquone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 250mg Major Manufacturers Table 3. 500mg Major Manufacturers Table 4. Global Atovaquone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Drug Store Major Manufacturers Table 7. Atovaquone Industry Trends Table 8. Atovaquone Industry Drivers Table 9. Atovaquone Industry Opportunities and Challenges Table 10. Atovaquone Industry Restraints Table 11. Global Atovaquone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Atovaquone Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Atovaquone Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Atovaquone Revenue Market Share by Region (2021-2026) Table 15. Global Atovaquone Revenue Market Share by Region (2027-2032) Table 16. Global Atovaquone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 17. Global Atovaquone Sales by Region (2021-2026) & (W Units) Table 18. Global Atovaquone Sales by Region (2027-2032) & (W Units) Table 19. Global Atovaquone Sales Market Share by Region (2021-2026) Table 20. Global Atovaquone Sales Market Share by Region (2027-2032) Table 21. Global Atovaquone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Atovaquone Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Atovaquone Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Atovaquone Sales Market Share by Manufacturers (2021-2026) Table 25. Global Atovaquone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Atovaquone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Atovaquone Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Atovaquone Manufacturers, Product Type & Application Table 29. Global Atovaquone Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Atovaquone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Atovaquone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Atovaquone Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Atovaquone Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Atovaquone Revenue Market Share by Type (2021-2026) Table 36. Global Atovaquone Revenue Market Share by Type (2027-2032) Table 37. Global Atovaquone Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 38. Global Atovaquone Sales by Type (2021-2026) & (W Units) Table 39. Global Atovaquone Sales by Type (2027-2032) & (W Units) Table 40. Global Atovaquone Sales Market Share by Type (2021-2026) Table 41. Global Atovaquone Sales Market Share by Type (2027-2032) Table 42. Global Atovaquone Price by Type (2021-2026) & (US$/Unit) Table 43. Global Atovaquone Price by Type (2027-2032) & (US$/Unit) Table 44. Global Atovaquone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Atovaquone Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Atovaquone Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Atovaquone Revenue Market Share by Application (2021-2026) Table 48. Global Atovaquone Revenue Market Share by Application (2027-2032) Table 49. Global Atovaquone Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 50. Global Atovaquone Sales by Application (2021-2026) & (W Units) Table 51. Global Atovaquone Sales by Application (2027-2032) & (W Units) Table 52. Global Atovaquone Sales Market Share by Application (2021-2026) Table 53. Global Atovaquone Sales Market Share by Application (2027-2032) Table 54. Global Atovaquone Price by Application (2021-2026) & (US$/Unit) Table 55. Global Atovaquone Price by Application (2027-2032) & (US$/Unit) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Atovaquone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. GSK Atovaquone Product Portfolio Table 60. GSK Recent Development Table 61. Amneal Pharmaceuticals Company Information Table 62. Amneal Pharmaceuticals Business Overview Table 63. Amneal Pharmaceuticals Atovaquone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Amneal Pharmaceuticals Atovaquone Product Portfolio Table 65. Amneal Pharmaceuticals Recent Development Table 66. Lupin Company Information Table 67. Lupin Business Overview Table 68. Lupin Atovaquone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Lupin Atovaquone Product Portfolio Table 70. Lupin Recent Development Table 71. Apotex Company Information Table 72. Apotex Business Overview Table 73. Apotex Atovaquone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Apotex Atovaquone Product Portfolio Table 75. Apotex Recent Development Table 76. North America Atovaquone Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Atovaquone Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Atovaquone Sales by Type (2021-2026) & (W Units) Table 79. North America Atovaquone Sales by Type (2027-2032) & (W Units) Table 80. North America Atovaquone Sales Price by Type (2021-2026) & (US$/Unit) Table 81. North America Atovaquone Sales Price by Type (2027-2032) & (US$/Unit) Table 82. North America Atovaquone Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Atovaquone Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Atovaquone Sales by Application (2021-2026) & (W Units) Table 85. North America Atovaquone Sales by Application (2027-2032) & (W Units) Table 86. North America Atovaquone Sales Price by Application (2021-2026) & (US$/Unit) Table 87. North America Atovaquone Sales Price by Application (2027-2032) & (US$/Unit) Table 88. North America Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Atovaquone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Atovaquone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Atovaquone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 92. North America Atovaquone Sales by Country (2021-2026) & (W Units) Table 93. North America Atovaquone Sales by Country (2027-2032) & (W Units) Table 94. North America Atovaquone Sales Price by Country (2021-2026) & (US$/Unit) Table 95. North America Atovaquone Sales Price by Country (2027-2032) & (US$/Unit) Table 96. United States Atovaquone Revenue (2021-2032) & (US$ Million) Table 97. Canada Atovaquone Revenue (2021-2032) & (US$ Million) Table 98. Europe Atovaquone Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Atovaquone Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Atovaquone Sales by Type (2021-2026) & (W Units) Table 101. Europe Atovaquone Sales by Type (2027-2032) & (W Units) Table 102. Europe Atovaquone Sales Price by Type (2021-2026) & (US$/Unit) Table 103. Europe Atovaquone Sales Price by Type (2027-2032) & (US$/Unit) Table 104. Europe Atovaquone Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Atovaquone Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Atovaquone Sales by Application (2021-2026) & (W Units) Table 107. Europe Atovaquone Sales by Application (2027-2032) & (W Units) Table 108. Europe Atovaquone Sales Price by Application (2021-2026) & (US$/Unit) Table 109. Europe Atovaquone Sales Price by Application (2027-2032) & (US$/Unit) Table 110. Europe Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Atovaquone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. Europe Atovaquone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. Europe Atovaquone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 114. Europe Atovaquone Sales by Country (2021-2026) & (W Units) Table 115. Europe Atovaquone Sales by Country (2027-2032) & (W Units) Table 116. Europe Atovaquone Sales Price by Country (2021-2026) & (US$/Unit) Table 117. Europe Atovaquone Sales Price by Country (2027-2032) & (US$/Unit) Table 118. Germany Atovaquone Revenue (2021-2032) & (US$ Million) Table 119. France Atovaquone Revenue (2021-2032) & (US$ Million) Table 120. U.K. Atovaquone Revenue (2021-2032) & (US$ Million) Table 121. Italy Atovaquone Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Atovaquone Revenue (2021-2032) & (US$ Million) Table 123. China Atovaquone Revenue by Type (2021-2026) & (US$ Million) Table 124. China Atovaquone Revenue by Type (2027-2032) & (US$ Million) Table 125. China Atovaquone Sales by Type (2021-2026) & (W Units) Table 126. China Atovaquone Sales by Type (2027-2032) & (W Units) Table 127. China Atovaquone Sales Price by Type (2021-2026) & (US$/Unit) Table 128. China Atovaquone Sales Price by Type (2027-2032) & (US$/Unit) Table 129. China Atovaquone Revenue by Application (2021-2026) & (US$ Million) Table 130. China Atovaquone Revenue by Application (2027-2032) & (US$ Million) Table 131. China Atovaquone Sales by Application (2021-2026) & (W Units) Table 132. China Atovaquone Sales by Application (2027-2032) & (W Units) Table 133. China Atovaquone Sales Price by Application (2021-2026) & (US$/Unit) Table 134. China Atovaquone Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Asia Atovaquone Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Atovaquone Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Atovaquone Sales by Type (2021-2026) & (W Units) Table 138. Asia Atovaquone Sales by Type (2027-2032) & (W Units) Table 139. Asia Atovaquone Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Asia Atovaquone Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Asia Atovaquone Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Atovaquone Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Atovaquone Sales by Application (2021-2026) & (W Units) Table 144. Asia Atovaquone Sales by Application (2027-2032) & (W Units) Table 145. Asia Atovaquone Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Asia Atovaquone Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Atovaquone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Asia Atovaquone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Asia Atovaquone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 151. Asia Atovaquone Sales by Country (2021-2026) & (W Units) Table 152. Asia Atovaquone Sales by Country (2027-2032) & (W Units) Table 153. Asia Atovaquone Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Asia Atovaquone Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Japan Atovaquone Revenue (2021-2032) & (US$ Million) Table 156. South Korea Atovaquone Revenue (2021-2032) & (US$ Million) Table 157. India Atovaquone Revenue (2021-2032) & (US$ Million) Table 158. Australia Atovaquone Revenue (2021-2032) & (US$ Million) Table 159. China Taiwan Atovaquone Revenue (2021-2032) & (US$ Million) Table 160. Southeast Asia Atovaquone Revenue (2021-2032) & (US$ Million) Table 161. SAMEA Atovaquone Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Atovaquone Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Atovaquone Sales by Type (2021-2026) & (W Units) Table 164. SAMEA Atovaquone Sales by Type (2027-2032) & (W Units) Table 165. SAMEA Atovaquone Sales Price by Type (2021-2026) & (US$/Unit) Table 166. SAMEA Atovaquone Sales Price by Type (2027-2032) & (US$/Unit) Table 167. SAMEA Atovaquone Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Atovaquone Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Atovaquone Sales by Application (2021-2026) & (W Units) Table 170. SAMEA Atovaquone Sales by Application (2027-2032) & (W Units) Table 171. SAMEA Atovaquone Sales Price by Application (2021-2026) & (US$/Unit) Table 172. SAMEA Atovaquone Sales Price by Application (2027-2032) & (US$/Unit) Table 173. SAMEA Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Atovaquone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. SAMEA Atovaquone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. SAMEA Atovaquone Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 177. SAMEA Atovaquone Sales by Country (2021-2026) & (W Units) Table 178. SAMEA Atovaquone Sales by Country (2027-2032) & (W Units) Table 179. SAMEA Atovaquone Sales Price by Country (2021-2026) & (US$/Unit) Table 180. SAMEA Atovaquone Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Brazil Atovaquone Revenue (2021-2032) & (US$ Million) Table 182. Argentina Atovaquone Revenue (2021-2032) & (US$ Million) Table 183. Chile Atovaquone Revenue (2021-2032) & (US$ Million) Table 184. Colombia Atovaquone Revenue (2021-2032) & (US$ Million) Table 185. Peru Atovaquone Revenue (2021-2032) & (US$ Million) Table 186. Saudi Arabia Atovaquone Revenue (2021-2032) & (US$ Million) Table 187. Israel Atovaquone Revenue (2021-2032) & (US$ Million) Table 188. UAE Atovaquone Revenue (2021-2032) & (US$ Million) Table 189. Turkey Atovaquone Revenue (2021-2032) & (US$ Million) Table 190. Iran Atovaquone Revenue (2021-2032) & (US$ Million) Table 191. Egypt Atovaquone Revenue (2021-2032) & (US$ Million) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Atovaquone Distributors List Table 195. Atovaquone Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Atovaquone Image Figure 2. Global Atovaquone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atovaquone Market Size Share 2021 VS 2025 VS 2032 Figure 4. 250mg Image Figure 5. 500mg Image Figure 6. Global Atovaquone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Atovaquone Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug Store Image Figure 10. Global Atovaquone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Atovaquone Revenue (2021-2032) & (US$ Million) Figure 12. Global Atovaquone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Atovaquone Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Atovaquone Revenue Market Share by Region (2021-2032) Figure 15. Global Atovaquone Sales (2021-2032) & (W Units) Figure 16. Global Atovaquone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 17. Global Atovaquone Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Atovaquone Sales YoY (2021-2032) & (W Units) Figure 19. Europe Atovaquone Sales YoY (2021-2032) & (W Units) Figure 20. China Atovaquone Sales YoY (2021-2032) & (W Units) Figure 21. Asia (Excluding China) Atovaquone Sales YoY (2021-2032) & (W Units) Figure 22. South America, Middle East and Africa Atovaquone Sales YoY (2021-2032) & (W Units) Figure 23. Global Atovaquone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Atovaquone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Atovaquone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Atovaquone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Atovaquone Revenue Market Share by Type (2021-2032) Figure 29. Global Atovaquone Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 30. Global Atovaquone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Atovaquone Sales Market Share by Type (2021-2032) Figure 32. Global Atovaquone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Atovaquone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Atovaquone Revenue Market Share by Application (2021-2032) Figure 35. Global Atovaquone Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Atovaquone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Atovaquone Sales Market Share by Application (2021-2032) Figure 38. North America Atovaquone Revenue Share by Type (2021-2032) Figure 39. North America Atovaquone Sales Share by Type (2021-2032) Figure 40. North America Atovaquone Revenue Share by Application (2021-2032) Figure 41. North America Atovaquone Sales Share by Application (2021-2032) Figure 42. North America Atovaquone Revenue Share by Country (2021-2032) Figure 43. North America Atovaquone Sales Share by Country (2021-2032) Figure 44. Europe Atovaquone Revenue Share by Type (2021-2032) Figure 45. Europe Atovaquone Sales Share by Type (2021-2032) Figure 46. Europe Atovaquone Revenue Share by Application (2021-2032) Figure 47. Europe Atovaquone Sales Share by Application (2021-2032) Figure 48. Europe Atovaquone Revenue Share by Country (2021-2032) Figure 49. Europe Atovaquone Sales Share by Country (2021-2032) Figure 50. China Atovaquone Revenue Share by Type (2021-2032) Figure 51. China Atovaquone Sales Share by Type (2021-2032) Figure 52. China Atovaquone Revenue Share by Application (2021-2032) Figure 53. China Atovaquone Sales Share by Application (2021-2032) Figure 54. Asia Atovaquone Revenue Share by Type (2021-2032) Figure 55. Asia Atovaquone Sales Share by Type (2021-2032) Figure 56. Asia Atovaquone Revenue Share by Application (2021-2032) Figure 57. Asia Atovaquone Sales Share by Application (2021-2032) Figure 58. Asia Atovaquone Revenue Share by Country (2021-2032) Figure 59. Asia Atovaquone Sales Share by Country (2021-2032) Figure 60. SAMEA Atovaquone Revenue Share by Type (2021-2032) Figure 61. SAMEA Atovaquone Sales Share by Type (2021-2032) Figure 62. SAMEA Atovaquone Revenue Share by Application (2021-2032) Figure 63. SAMEA Atovaquone Sales Share by Application (2021-2032) Figure 64. SAMEA Atovaquone Revenue Share by Country (2021-2032) Figure 65. SAMEA Atovaquone Sales Share by Country (2021-2032) Figure 66. Atovaquone Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Atovaquone Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 250mg
  • 500mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • GSK
  • Amneal Pharmaceuticals
  • Lupin
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atovaquone Market by Type
  3. 1.2.1 Global Atovaquone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 250mg
  5. 1.2.3 500mg
  6. 1.3 Atovaquone Market by Application
  7. 1.3.1 Global Atovaquone Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug Store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Atovaquone Market Dynamics
  1. 2.1 Atovaquone Industry Trends
  2. 2.2 Atovaquone Industry Drivers
  3. 2.3 Atovaquone Industry Opportunities and Challenges
  4. 2.4 Atovaquone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atovaquone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atovaquone Revenue by Region
  3. 3.2.1 Global Atovaquone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atovaquone Revenue by Region (2021-2026)
  5. 3.2.3 Global Atovaquone Revenue by Region (2027-2032)
  6. 3.2.4 Global Atovaquone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atovaquone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atovaquone Sales by Region
  9. 3.4.1 Global Atovaquone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atovaquone Sales by Region (2021-2026)
  11. 3.4.3 Global Atovaquone Sales by Region (2027-2032)
  12. 3.4.4 Global Atovaquone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atovaquone Revenue by Manufacturers
  2. 4.1.1 Global Atovaquone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atovaquone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atovaquone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atovaquone Sales by Manufacturers
  6. 4.2.1 Global Atovaquone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atovaquone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atovaquone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atovaquone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atovaquone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atovaquone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atovaquone Manufacturers, Product Type & Application
  13. 4.7 Global Atovaquone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atovaquone Market CR5 and HHI
  16. 4.8.2 2025 Atovaquone Tier 1, Tier 2, and Tier 3
5 Atovaquone Market by Type
  1. 5.1 Global Atovaquone Revenue by Type
  2. 5.1.1 Global Atovaquone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atovaquone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atovaquone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atovaquone Sales by Type
  6. 5.2.1 Global Atovaquone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atovaquone Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Atovaquone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atovaquone Price by Type
6 Atovaquone Market by Application
  1. 6.1 Global Atovaquone Revenue by Application
  2. 6.1.1 Global Atovaquone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atovaquone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atovaquone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atovaquone Sales by Application
  6. 6.2.1 Global Atovaquone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atovaquone Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Atovaquone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atovaquone Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Atovaquone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Atovaquone Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Amneal Pharmaceuticals
  8. 7.2.1 Amneal Pharmaceuticals Company Information
  9. 7.2.2 Amneal Pharmaceuticals Business Overview
  10. 7.2.3 Amneal Pharmaceuticals Atovaquone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amneal Pharmaceuticals Atovaquone Product Portfolio
  12. 7.2.5 Amneal Pharmaceuticals Recent Developments
  13. 7.3 Lupin
  14. 7.3.1 Lupin Company Information
  15. 7.3.2 Lupin Business Overview
  16. 7.3.3 Lupin Atovaquone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lupin Atovaquone Product Portfolio
  18. 7.3.5 Lupin Recent Developments
  19. 7.4 Apotex
  20. 7.4.1 Apotex Company Information
  21. 7.4.2 Apotex Business Overview
  22. 7.4.3 Apotex Atovaquone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Apotex Atovaquone Product Portfolio
  24. 7.4.5 Apotex Recent Developments
8 North America
  1. 8.1 North America Atovaquone Market Size by Type
  2. 8.1.1 North America Atovaquone Revenue by Type (2021-2032)
  3. 8.1.2 North America Atovaquone Sales by Type (2021-2032)
  4. 8.1.3 North America Atovaquone Price by Type (2021-2032)
  5. 8.2 North America Atovaquone Market Size by Application
  6. 8.2.1 North America Atovaquone Revenue by Application (2021-2032)
  7. 8.2.2 North America Atovaquone Sales by Application (2021-2032)
  8. 8.2.3 North America Atovaquone Price by Application (2021-2032)
  9. 8.3 North America Atovaquone Market Size by Country
  10. 8.3.1 North America Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atovaquone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atovaquone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Atovaquone Market Size by Type
  2. 9.1.1 Europe Atovaquone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atovaquone Sales by Type (2021-2032)
  4. 9.1.3 Europe Atovaquone Price by Type (2021-2032)
  5. 9.2 Europe Atovaquone Market Size by Application
  6. 9.2.1 Europe Atovaquone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atovaquone Sales by Application (2021-2032)
  8. 9.2.3 Europe Atovaquone Price by Application (2021-2032)
  9. 9.3 Europe Atovaquone Market Size by Country
  10. 9.3.1 Europe Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atovaquone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atovaquone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Atovaquone Market Size by Type
  2. 10.1.1 China Atovaquone Revenue by Type (2021-2032)
  3. 10.1.2 China Atovaquone Sales by Type (2021-2032)
  4. 10.1.3 China Atovaquone Price by Type (2021-2032)
  5. 10.2 China Atovaquone Market Size by Application
  6. 10.2.1 China Atovaquone Revenue by Application (2021-2032)
  7. 10.2.2 China Atovaquone Sales by Application (2021-2032)
  8. 10.2.3 China Atovaquone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atovaquone Market Size by Type
  2. 11.1.1 Asia Atovaquone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atovaquone Sales by Type (2021-2032)
  4. 11.1.3 Asia Atovaquone Price by Type (2021-2032)
  5. 11.2 Asia Atovaquone Market Size by Application
  6. 11.2.1 Asia Atovaquone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atovaquone Sales by Application (2021-2032)
  8. 11.2.3 Asia Atovaquone Price by Application (2021-2032)
  9. 11.3 Asia Atovaquone Market Size by Country
  10. 11.3.1 Asia Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atovaquone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atovaquone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atovaquone Market Size by Type
  2. 12.1.1 SAMEA Atovaquone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atovaquone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atovaquone Price by Type (2021-2032)
  5. 12.2 SAMEA Atovaquone Market Size by Application
  6. 12.2.1 SAMEA Atovaquone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atovaquone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atovaquone Price by Application (2021-2032)
  9. 12.3 SAMEA Atovaquone Market Size by Country
  10. 12.3.1 SAMEA Atovaquone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atovaquone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atovaquone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atovaquone Value Chain Analysis
  2. 13.1.1 Atovaquone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atovaquone Production Mode & Process
  6. 13.2 Atovaquone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atovaquone Distributors
  9. 13.2.3 Atovaquone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst